Results 171 to 180 of about 28,581 (233)

Blastocyst-Derived Lactic Acid Regulates Uterine Epithelial Receptivity and Stromal Decidualization via the HIF1α-HO-1-Heme Metabolic Axis. [PDF]

Antioxidants (Basel)
Yao WX, Ma YD, Ding SY, Lu J, Tang HL, Yang ZM.   +5 more
europepmc   +1 more source

Cross-Species Analysis of Milk Extracellular Vesicles Reveals a Conserved Innate Core and a Divergent, Human-Specific Adaptive Immune Fraction. [PDF]

Int J Mol Sci
Papakonstantinou E, Chrousos GP, Vlachakis D.   +2 more
europepmc   +1 more source

Flow-cytometric profiling of large extracellular vesicles as immunophenotypic biomarkers in head and neck squamous cell carcinoma. [PDF]

Cancer Immunol Immunother
Büntzel J, Maulhardt M, Angleitner AC, Schulz M, Köberle D, Naser S, Zwerenz C, Pagel CF, Hille A, Hund AC, Büntzel J.   +10 more
europepmc   +1 more source

From Glycocode to Precision Oncology: Therapeutic Strategies Targeting Aberrant O-GalNAc Glycosylation in Cancer. [PDF]

Chem Rev
Aasted MKM, Jaroentomeechai T, Dabelsteen S, Joshi H, Stowell SR, Wandall HH.   +5 more
europepmc   +1 more source

Eradicating <i>Helicobacter pylori</i> and reversing precancerous intestinal metaplasia by gastric epithelial cells-localizable oral nanomedicines. [PDF]

Bioact Mater
Ma S, Zhang Z, Hao J, Li J, Lu B, Hao S, Fan Y, Yu S, Liu J, Hu H.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Muc1 Immunotherapy

Immunotherapy, 2010
The overexpression and aberrant glycosylation of MUC1 is associated with a wide variety of cancers, making it an ideal target for immunotherapeutic strategies. This review highlights the main avenues of research in this field, focusing on adenocarcinomas, from the preclinical to clinical; the problems and possible solutions associated with each ...
Beatson, Richard, Burchell, Joy, Taylor-Papadimitriou, Joyce   +2 more
openaire   +3 more sources